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Abstract
We estimated the frequency and direct medical cost from the provider perspective of U.S. hospital 
visits for pediatric abusive head trauma (AHT). We identified treat-and-release hospital 
emergency department (ED) visits and admissions for AHT among patients aged 0–4 years in the 
Nationwide Emergency Department Sample and Nationwide Inpatient Sample (NIS), 2006–2011. 
We applied cost-to-charge ratios and estimated professional fee ratios from Truven Health 
MarketScan® to estimate per-visit and total population costs of AHT ED visits and admissions. 
Regression models assessed cost differences associated with selected patient and hospital 
characteristics. AHT was diagnosed during 6,827 (95% confidence interval [CI] [6,072, 7,582]) 
ED visits and 12,533 (95% CI [10,395, 14,671]) admissions (28% originating in the same 
hospital’s ED) nationwide over the study period. The average medical cost per ED visit and 
admission were US$2,612 (error bound: 1,644–3,581) and US$31,901 (error bound: 29,266–
34,536), respectively (2012 USD). The average total annual nationwide medical cost of AHT 
hospital visits was US$69.6 million (error bound: 56.9–82.3 million) over the study period. 
Factors associated with higher per-visit costs included patient age <1 year, males, coexisting 
chronic conditions, discharge to another facility, death, higher household income, public insurance 
payer, hospital trauma level, and teaching hospitals in urban locations. Study findings emphasize 
the importance of focused interventions to reduce this type of high-cost child abuse.
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While the severity and public health significance of shaken baby syndrome, or pediatric 
abusive head trauma (AHT), has long been recognized, an administrative code-based 
definition of AHT with demonstrated accuracy from the Centers for Disease Control and 
Prevention (CDC) recently made it possible to investigate the health and financial impact of 
AHT on a consistent basis using U.S. nationwide data (Berger, Parks, Fromkin, Rubin, & 
Pecora, 2013; S. Parks, Annest, Hill, & Karch, 2012). Population-based studies using that 
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definition have since separately reported the statewide or nationwide frequency of AHT 
mortality (S. E. Parks, Kegler, Annest, & Mercy, 2012), hospital inpatient admissions 
(Niederkrotenthaler, Xu, Parks, & Sugerman, 2013; S. Parks, Sugerman, Xu, & Coronado, 
2012; Shanahan, Zolotor, Parrish, Barr, & Runyan, 2013), or emergency department (ED) 
visits (Selassie, Borg, Busch, & Russell, 2013; Xiang et al., 2013). However, no previous 
study has reported annual nationwide estimates of comprehensive hospital services 
(emergency and inpatient) for AHT and associated costs using the CDC definition.
Rigorous estimates of medical costs and resource use related to AHT are limited. A recent 
multistate study retrospectively assessed a large sample of AHT patients’ individual medical 
costs from a payer perspective over several years, although that study was limited to patients 
with specific insurance types and could not assess nationwide frequency of AHT medical 
services (Peterson et al., 2014). In this study, we estimated the U.S. nationwide annual 
frequency of hospital emergency and inpatient visits for AHT, related direct medical costs 
from the provider perspective, and associations between AHT patient characteristics and 
hospital visit costs.
Methods
We identified treat-and-release hospital ED visits and inpatient admissions during which 
AHT was diagnosed (hereafter referred to as AHT ED visits or admissions, or collectively as 
AHT hospital visits) among patients aged 0–4 years in the 2006–2011 Nationwide 
Emergency Department Sample (NEDS) and Nationwide Inpatient Sample (NIS) from the 
Healthcare Cost and Utilization Project (HCUP). ED visits and admissions were included in 
this analysis if a combination of International Classification of Diseases, Ninth Revision, 
Clinical Modification, and External Cause of Injury (E-codes) diagnosis codes indicated 
definite or probable AHT based on a recent CDC definition (S. Parks, Annest, et al., 2012). 
AHT is defined by that source as an injury to the skull or intracranial contents of an infant or 
young child (<5 years of age) due to inflicted blunt impact and/or violent shaking, excluding 
unintentional injuries resulting from neglectful supervision, as well as penetrating trauma 
such as gunshot or stab wounds (S. Parks, Annest, et al., 2012). The primary outcome 
measures in this study were the total number of AHT ED visits and admissions annually, the 
total direct medical cost from the provider perspective of AHT ED visits and admissions 
annually, and the average costs per AHT ED visit and admission over the study period. 
Secondary end points were the proportion of AHT admissions by source (i.e., ED, another 
facility, etc.) and estimated associations between per-visit costs and selected patient 
characteristics. This study used publicly available data.
Data
NEDS and NIS are the largest publicly available, all-payer, hospital-based ED and inpatient 
care databases, respectively, in the United States (Healthcare Cost and Utilization Project, 
2013b, 2013c). These databases consist of stratified samples of discharge information, 
representative of the U.S. population, for patients with all health care payer types, including 
public insurance (i.e., Medicare and Medicaid), private insurance, and no insurance. The 
annual NEDS data assessed for this study were based on 26–29 million ED visits annually 
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(representing 120–129 million visits, with survey weights) to 955–961 hospitals in 24–28 
states (Healthcare Cost and Utilization Project, 2013b). The annual NIS data assessed for 
this study included approximately 8 million inpatient admissions annually (representing 38–
39 million admissions, with survey weights) to 1,045–1,049 hospitals in 38–46 states 
(Healthcare Cost and Utilization Project, 2013c). NEDS and NIS report one discharge 
record per ED visit or admission and patients are not uniquely identified; therefore, analyses 
of these databases are presented in terms of per-visit and per-admission results, rather than 
per-patient results.
In this study, we used NEDS data to assess ED-only visits, defined as visits by patients 
routinely discharged, transferred to other facilities, leaving against medical advice, and those 
who died. Our methods for classifying ED treat-and-release and inpatient visits and inpatient 
admissions ensured nonoverlapping, comprehensive visit count and cost estimates. NEDS 
reports ED-only hospital charges for ED visits. We included patients who were transferred 
to other facilities in our ED treat-and-release estimates because this approach was required 
to comprehensively capture nationwide AHT hospital costs (i.e., if a patient was transferred 
from an ED to separate inpatient facility, the NIS data set would only report that patient’s 
inpatient costs, excluding the ED costs from the originating facility). NIS reports inpatient 
admissions originating from all sources and reports total hospital charges per admission. In 
the NIS data set, ED charges are included only for ED services provided within the same 
facility.
Cost Estimates
NEDS and NIS report hospitals’ facility-only charges (i.e., room and board) submitted to 
health care payers; physician, or professional, fees (i.e., payments to attending physicians, 
not directly employed by the hospital) are not included (Healthcare Cost and Utilization 
Project, 2011, 2012). The price that a hospital charges for its services is often greater than 
the amount the hospital is actually paid, or reimbursed, by an insurance company or 
individual. However, unlike hospital charges data, which are available from a number of 
publicly available, aggregated sources such as HCUP, hospital reimbursement data are 
commonly captured in proprietary data sets held by individual insurance companies and 
hospital organizations. Accepted methods are available to estimate hospitals’ costs from 
charges data; the cost perspective in this case is referred to as the provider perspective. If 
instead insurance reimbursement data are used to estimate the cost of hospital services, the 
cost perspective is referred to as the payer perspective. Although different data and methods 
are used to estimate medical costs under these two perspectives, these approaches should 
yield similar cost estimates. Limited recent research directly comparing these approaches 
suggests that methods used to estimate hospital costs from charges data can produce a 
reasonable proxy for payments hospitals receive (Levit, Friedman, & Wong, 2013).
We applied two conversions to reported facility-only charges in the NEDS and NIS to 
estimate total costs for AHT ED visits and admissions: a cost-to-charge ratio (CCR; 
published by HCUP for this purpose) used to estimate facility costs based on facility charges 
and a professional fee ratio (PFR) used to estimate the cost of professional services when 
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only facility costs are known. All estimated costs are reported as 2012 USD, inflated using 
the U.S. Producer Price Index for hospitals (U.S. Bureau of Labor Statistics).
Annual, all-payer, hospital-specific, inpatient CCR are calculated by the U.S. Centers for 
Medicare and Medicaid Services and published by HCUP for use with the NIS data 
(Healthcare Cost and Utilization Project, 2013a). When the annual, hospital-specific CCR 
was not available (n = 61/400, or 15% of unique annual hospital records with AHT 
admissions), we applied the annual, hospital group-average CCR, as recommended by 
HCUP (Healthcare Cost and Utilization Project, 2013a). When both hospital-specific and 
group-average CCR were unavailable (n = 13/400, or 3% of annual hospital records), we 
used multiple imputation based on selected characteristics (i.e., admission year and 
hospitals’ regional location, urban/rural location, teaching status, and bed size—hospital 
ownership was ambiguous for 88% of hospitals in our sample and was not used for 
imputation) to estimate hospitals’ annual, hospital-specific CCR based on reported CCR 
among similar hospitals (Healthcare Cost and Utilization Project, 2013a). While this type of 
imputed CCR is not specifically prescribed by HCUP, this approach was deemed preferable 
to alternatives such as eliminating observations for which no hospital CCR was available or 
using a general average CCR for missing values. After these steps were undertaken, the 
average inpatient CCR applied to AHT facility-only inpatient charges over the entire study 
period was 0.376 (standard error [SE] = 0.013), suggesting that hospitals’ facility cost to 
provide services were, on average, just 38% of facility-only charges submitted to payers for 
AHT admissions.
HCUP does not publish CCR for NEDS data and hospitals in the NEDS data are not 
identified for linking to NIS data (Friedman & Owens, 2007). There is limited evidence that 
CCR for inpatient admissions is correlated with CCR for ED visits, although inpatient CCR 
may underestimate ED CCR (Friedman & Owens, 2007). With available data, we applied 
average inpatient CCR from hospitals with AHT admissions we had identified in the NIS 
data (including imputed CCR) to AHT ED visits in the NEDS data based on visit year, 
hospitals’ regional location, urban/rural location, and teaching status (i.e., an AHT ED visit 
at an urban teaching hospital in the Midwest was assigned the average inpatient CCR for all 
hospitals matching those criteria with AHT admissions that year in our inpatient sample). 
For ED visits that could not be matched in this way (n = 276/6,827, or 4% of AHT ED 
visits), we assigned the annual average inpatient CCR for all hospitals that year with AHT 
admissions. The average CCR applied to NEDS facility-only charges for AHT ED visits 
over the entire study period was 0.380 (SE = 0.004).
To account for professional fees during AHT ED visits and admissions reported in NEDS 
and NIS, we applied PFR estimated from AHT ED visits and inpatient admissions identified 
in the 2006–2011 Truven Health MarketScan® database for a separate study (Peterson et al., 
2014). MarketScan is a multi-state health insurance claims database that reports patient-level 
payments (or reimbursements) to health care providers for patients with selected employer-
based and Medicaid health insurance (Truven Health Analytics, 2013). MarketScan is not 
nationally representative, and Medicaid data from approximately a dozen states are included. 
MarketScan separately reports facility and physician payments to hospitals for ED visits and 
inpatient admissions. Using MarketScan data for AHT patients with noncapitated health 
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insurance plans, we calculated the average annual, payer-specific (i.e., commercial or 
Medicaid) PFR per AHT ED visit and admission. We found statistically significant group 
differences in PFR for AHT ED visits based on payer type in the MarketScan data; 
therefore, we applied payer-specific PFR (mean commercial insurance PFR for ED visits: 
1.49, 95% confidence interval [CI] [1.33, 1.66], n = 205; mean Medicaid PFR for ED visits: 
2.10, 95% CI [1.89, 2.32], n = 93) to estimate total costs per AHT ED visit reported in 
NEDS. There was no significant payer difference in inpatient PFR for AHT admissions as 
estimated with the MarketScan data; therefore, we uniformly applied an average PFR of 
1.24, regardless of payer type, to estimate total costs per AHT admission reported in NIS.
Analysis
We first estimated the annual nationwide number of AHT ED visits, admissions, and 
associated total and per-visit average costs. We then used multivariable, survey-weighted, 
generalized linear models with gamma variance and the log link function to estimate 
associations between estimated per-visit costs and selected patient characteristics (Manning, 
Basu, & Mullahy, 2005). The statistical variation reported with our cost results is based only 
on the 95% CIs around HCUP survey weights (i.e., the count and cost of a particular AHT 
visit was assigned a statistical weighting based on standard HCUP sample methods) and not 
the additional elements we used to estimate hospital costs from HCUP’s hospital charge data 
(i.e., CCR, which was applied to each observation as a hospital-specific, group-average, or 
imputed single value, as described previously, and PFR, which was applied to each 
observation as a payer-specific average for ED visits or a general average for inpatient 
admissions, as also described previously); therefore, the variation around the cost estimates 
is referred to as an error bound, rather than a 95% CI descriptive analysis was conducted 
with SAS 9.3 (Cary, NC) and regression models were estimated with Stata 13® (College 
Station, TX) software.
Results
The survey-weighted estimated annual number of AHT treat-and-release ED visits 2006–
2011 ranged from 1,009 (2010; 95% CI [824, 1,193]) to 1,223 (2007; 95% CI [963, 1,482]), 
with an annual average of 1,138 (95% CI [1,012, 1,264]) over the study period (Table 1). 
The estimated number of AHT admissions ranged from 1,790 (2011; 95% CI [1,050, 2,531]) 
to 2,688 (2010; 95% CI [1,884, 3,492]) annually, with an annual average of 2,089 (95% CI 
[1,732, 2,445]) over the study period. AHT was diagnosed during a total of 6,827 (95% CI 
[6,072, 7,582]) ED visits and 12,533 (95% CI [10,395, 14,671]) admissions nationwide over 
the study period (data for total visits not shown; the total number of visits during the study 
period does not reflect the sum of all years due to rounding). Based on overlapping CIs, 
there were no significant temporal trends in ED visits, admissions, or costs over the study 
period. In total, 28% (n = 3,563/12,533) of total AHT admissions over the period originated 
in the same hospital’s ED (data not shown).
The estimated average annual costs per ED visit and inpatient admission were US$2,612 
(error bound: 1,644–3,581) and US$31,901 (error bound: 29,266–34,536), respectively, over 
the study period (2012 USD; Table 1). The estimated combined cost of all AHT ED visits 
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and admissions over the study period ranged from US$58.9 million annually (2011; error 
bound: 35.0–82.9 million) to US$98.5 million (2010; error bound: 65.3–131.6 million), with 
an annual average of US$69.6 million (error bound: 56.9–82.3 million; Table 1).
In multivariable models, AHT patients’ discharge to another facility for continued medical 
care after an ED visit or death during an ED visit were each associated with over 3 times the 
cost of an ED visit from which a patient was routinely discharged, exp(β) = 3.04, 95% CI 
[2.49, 3.71] and 3.70, 95% CI [1.97, 6.97], respectively (Table 2). AHT inpatients’ 
discharge to another facility or death during an admission were also associated with higher 
costs. Other factors associated with higher per-visit costs included patient age <1 year (ED 
visits only), male sex (admissions only), coexisting chronic conditions (both ED visits and 
admissions), higher household income (admissions only), public insurance payer (ED visits 
only), hospitals with trauma-level ED (ED visits only, not reported for admissions), and 
teaching hospitals in urban locations (ED visits only; Table 2).
Discussion
To our knowledge, this analysis is the first to describe the combined annual frequency of 
emergency and inpatient hospital visits and associated costs for AHT at the nationwide 
level. Over the study period, the cost of AHT hospital care amounted to tens of millions of 
dollars annually. We used multiple nationwide data sets to create nonoverlapping, 
comprehensive estimates of AHT emergency and inpatient hospital visits. We used 
recommended methods to estimate hospital facility costs from publicly available data on 
hospital facility charges and derived estimates of professional fees from a separate data 
source to achieve comprehensive hospital visit cost estimates.
Consistent with a previous study of AHT inpatient admissions (over nonconsecutive years; 
Shanahan et al., 2013), we observed no significant temporal trends in the number of AHT 
visits, nor costs, over the study period. It is difficult to directly compare the AHT hospital 
visit frequency estimates we reported here to previous population-based studies—previous 
nationwide studies variously assessed a combination of narrower patient age ranges (such as 
<1 or <2 years; Niederkrotenthaler et al., 2013; Shanahan et al., 2013) or included different 
categories of inpatient admissions (i.e., limited to nonfatal admissions; S. Parks, Sugerman, 
et al., 2012) and ED visits (Xiang et al., 2013) over earlier study periods.
Clinicians might be surprised at the number of AHT patients treated and released from an 
ED without admission reported in our results. One study using only NEDS data previously 
reported over a third of patients treated for AHT in an ED were treated and released (Xiang 
et al., 2013). The only other study we are aware of that examined both ED and inpatient 
experiences for AHT patients reported 17% of such patients were not treated as inpatients 
within 2 days of their first AHT diagnosis (Peterson et al., 2014). Neither this study nor 
previous studies offered opportunities to further examine the experiences of AHT patients 
who were not admitted.
In a previous study of per-patient AHT direct medical costs using MarketScan provider 
reimbursement data from selected insurance payers (i.e., payer cost perspective), we 
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examined the average reimbursement for a patient’s initial ED visit or admission during 
which AHT was diagnosed (Peterson et al., 2014). The estimated cost of an initial AHT 
admission from that study (US$29,791; 95% CI [25,612, 33,971]) overlapped the error 
bound of the nationwide estimate for AHT admissions among patients with all insurance 
payer types we reported in this study (i.e., provider cost perspective; US$31,901, error 
bound: 29,266–34,536; both 2012 USD), where we could not observe whether the AHT 
admission was related to an initial AHT diagnosis, a subsequent AHT event, or follow-up 
AHT treatment. The average insurance reimbursement for a patient’s initial AHT ED visit in 
the previous study (US$685; 95% CI [567, 802]) was significantly lower than the average 
AHT ED visit cost reported in this study (US$2,612, error bound: 1,644–3,581). The 
previous study included earlier study years (i.e., 2003–2011) and it is possible that changes 
over time beyond medical cost inflation affected the average cost of AHT ED visits we 
reported in the previous study. The previous study included only initial ED visits for AHT 
patients, while in this study, we could not observe whether children were returning to the ED 
for multiple AHT injuries; it is possible that children with multiple AHT injuries and ED 
visits could sustain more severe injuries, requiring more costly ED treatment. The previous 
study included only selected health insurance payer types, while this study included all 
payer types.
Peterson et al. (2014) also reported a per-person total attributable medical cost of AHT in 
the 4 years following patients’ initial diagnosis, including inpatient, outpatient, and drugs 
costs (US$47,952, 95% CI [US$40,219, US$55,685]; 2012 USD; Peterson et al., 2014). 
Despite many advantages of the MarketScan data used for that estimate, its limitations are 
that it reflects only selected health insurance payers and that it cannot provide nationwide 
estimates of the number of children treated for AHT; neither of those limitations apply to the 
HCUP data we used for the present analysis. On the other hand, HCUP provides only 
hospital financial data (i.e., not outpatient or drugs data), various estimates are required to 
convert HCUP’s reported hospital facility charges to estimated total hospital visit costs, and 
HCUP data cannot be used to track patients’ health care experiences and costs over time. 
Further, this analysis estimated the total cost of hospital visits during which AHT was 
diagnosed, and the cost estimates reported here do not cleanly estimate the attributable, or 
excess, hospital cost of AHT. Estimates of the attributable cost of a health condition require 
eliminating medical costs that would have occurred to affected patients even in the absence 
of the condition under investigation. Such estimates usually require patient-level data and a 
patient control group, which is not consistent with what is available in the HCUP nationwide 
NEDS and NIS samples (Brown, Fang, & Florence, 2011).
Unfortunately, we are not aware of any nationwide data set that would allow us to examine 
total attributable health care costs for a relatively rare condition like AHT. Aside from the 
benefits and drawbacks of the data sources used to derive the different AHT medical cost 
estimates reported in Peterson et al. (2014) and the present analysis, the reported cost 
estimates can have different research and communication purposes: Studies of long-term 
per-patient medical costs of health conditions (i.e., Peterson et al., 2014) can be used in 
economic evaluations to assess the cost-effectiveness of proven interventions, while 
population-based annual medical cost estimates of those conditions (i.e., the present 
analysis) are relevant to examine population trends and contextualize public health issues.
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Other recent studies have estimated the average medical and lifetime cost of all types of 
child maltreatment, including physical abuse, sexual abuse, emotional abuse, and neglect 
(Fang, Brown, Florence, & Mercy, 2012; Florence, Brown, Fang, & Thompson, 2013). 
Perhaps not surprising given that AHT is an extremely severe form of physical abuse, our 
study suggests AHT has high average acute care costs per child (on average, US$2,612 for a 
single ED visit and US$31,901 for a single hospitalization) compared to the entire average 
per-child annual medical cost (including payments to providers for inpatient services, 
outpatient services, and drugs) of maltreated children documented in those papers 
(approximately US$2,600, 2009 USD). A 2011 systematic literature review on the medical 
cost of all types of child maltreatment identified just one previous financial study of AHT 
(Brown et al., 2011; Ettaro, Berger, & Songer, 2004). That study, however, reported only 
hospital charges, which are not a meaningful indicator of medical costs and are not 
comparable to the cost estimates we reported here.
This study estimated higher per-visit AHT hospital costs based on a number of 
sociodemographic factors. It is possible that many of the significant estimated associations 
between AHT hospital costs and patient-level factors such as age, sex, and discharge status 
were driven by injury severity, which we could not directly observe for this analysis. The 
estimated significant associations between household income and admission costs, and 
health insurance payer and ED visit cost, could be related to hospital-level characteristics 
that we also could not observe for this analysis. The significantly higher per-ED visit costs 
for AHT patients with public payers could also be related to differences in care-seeking 
behavior between publicly and privately insured populations, such as deferred care for 
conditions unrelated to AHT that was administered during ED visits in our sample, resulting 
in higher total visit costs. Our models attempted to control for the cost of non-AHT care by 
controlling for AHT patients with specific chronic conditions, although this approach clearly 
does not address all types of additional care that AHT patients might have received. 
Differences in care-seeking behavior might also explain why the PFR for ED visits among 
Medicaid AHT patients was higher than the PFR for privately insured patients as measured 
in the MarketScan sample of AHT patients. Alternatively, higher PFR for Medicaid AHT 
visits could be related to charging and reimbursement differences between Medicaid and 
private insurers for ED care, which we could not observe in this analysis. This study 
observed significantly higher AHT ED visit costs among trauma hospitals. This could be 
related to several factors, including higher capital costs in such hospitals, or selection bias 
that resulted in more severely injured patients being routed to such facilities.
This analysis had a number of limitations. The statistical variation reported for our cost 
results underestimates the true variation because it was based only on HCUP survey weights 
and did not include variation around the contributing cost elements. We used the accepted 
method for estimating hospital costs from hospital charges data—hospital-wide CCR for 
individual centers published by HCUP. But CCR varies within hospitals by department; 
therefore, a single hospital-wide CCR applied to total hospital charges for each AHT 
hospital visit is an imprecise measure of hospitals’ true cost to treat AHT patients. Using 
average annual inpatient CCR to estimate ED visit costs from hospital facility only charges 
is also a limitation. For 3% of inpatient records, we lacked both hospital-specific and group-
average CCR and we used an imputation method. We used a data source—MarketScan—
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that is not nationally representative to estimate professional fees for AHT hospital visits. 
The cost of professional fees for AHT hospital visits is not zero; therefore, using feasible 
methods to estimate such fees seems preferable to ignoring such fees altogether. MarketScan 
includes both private and Medicaid payment information from multiple regions of the 
United States, and provides as defensible a data source as any we are aware of to estimate 
PFR for this analysis. Some professional charges may be included in hospitals’ facility bill. 
We applied estimated PFR to all AHT ED visits and admissions; therefore, we might have 
overestimated the total cost of some ED visits and admissions by double-counting some 
professional fees.
Our regression analyses suggested significantly higher ED visit and inpatient admission 
costs among patients with co-occurring chronic conditions (Table 2). It was not possible to 
assess whether that apparent cost difference was due to patients receiving treatment that 
should not have been attributed to AHT, in which case our results might have overestimated 
the cost of AHT hospital care. We were not able to distinguish initial AHT hospital visits 
from subsequent visits for the same type of abuse. It may be that due to the severe nature of 
AHT injuries, AHT is more accurately coded for acute, directly attributable medical 
treatment, and not as well coded for follow-up hospital-based treatment for related sequelae. 
If that is the case, our results might instead underestimate the total attributable annual cost of 
AHT hospital care. The total estimates of AHT hospital costs presented here likely 
underestimate the true total AHT hospital cost burden due to a separate issue, which is the 
documented underreporting of AHT in medical records (Jenny, Hymel, Ritzen, Reinert, & 
Hay, 1999; S. Parks, Annest, et al., 2012). Prospective, longitudinal patient studies could 
provide robust estimates of AHT patients’ long-term medical needs and associated costs. 
Information on AHT patients’ out of pocket costs, caregiver costs, and long-term costs such 
as special education could improve understanding of the total burden on individuals affected 
by this type of abuse.
Despite limitations, this study benefited from nationwide representativeness and several 
adjustments to estimate total per-visit hospital costs based on available financial data in two 
well-recognized sample data sets. This research contributes to the growing number of 
studies documenting nationwide information on AHT, made possible through a uniform 
code-based definition recently published by the CDC (S. Parks, Annest, et al., 2012). Total 
annual direct AHT hospital cost estimates can be used by researchers, practitioners, and 
policy makers to describe AHT in a public health context. The cost estimates presented here 
did not include the cost of nonhospital medical care or the long-term associated costs of 
special education and developmental services that many AHT patients require. But the total 
cost of hospital care alone for AHT on a nationwide level is substantial. Given these high 
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